Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRII - Cell Robotics International, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: sheetmillgalvanize who wrote (224)	10/7/1999 10:09:00 AM
From: sheetmillgalvanize	Read Replies (1) \| Respond to of 252

Thursday October 7, 8:01 am Eastern Time Company Press Release Cell Robotics Initiates Pilot Production of the Personal Lasette ALBUQUERQUE, N.M.--(BW HealthWire)--Oct. 7, 1999--Cell Robotics International Inc. (OTC BB: CRII - news) Thursday announced that it has initiated pilot production of the Personal Lasette©, a laser finger perforator to draw blood for glucose testing in a nearly painless manner. The first units will be shown today at the RCG Growth Stock Conference at the Phoenician Resort in Scottsdale, Ariz. Several of these units will be shipped to Chronimed Inc. (Nasdaq: CHMD - news) for final analysis in preparation of the product launch. The Personal Lasette is designed for home-use by diabetics to draw their blood for testing their glucose levels. The rechargeable battery powered Personal Lasette is about the size of a cell phone, weights only 8 ounces and comes with a disposable film cartridge that automatically advances for 120 shots. The industrial design of the Personal Lasette may be seen at cellrobotics.com. Cell Robotics' Lasette technology and design has won both the Phontonics Spectra's ``Circle of Excellence Award' for one of the 25 most technically innovative laser products of the year and the prestigious R&D Magazine's ``R&D 100 Award' as one of the 100 most innovative technical developments for the year. It is also the only technology other than steel lancets or needles cleared by the FDA to draw blood for glucose testing and is the only medical laser cleared for home-use for any application. In the United States alone at least 4.7 million people are required to test their glucose levels multiple times every day. Cell Robotics International Inc. also manufactures, markets, and sells the In Vitro Fertilization (IVF) Workstation (used in Laser Assisted Hatching and Zona Laser Treatment), and the Cell Robotics Workstation, a research instrument that incorporates the LaserTweezers© and LaserScissors(TM) for manipulating and cutting cells and chromosomes. Additional information is available on the Cell Robotics Web Site, by e-mail at crii@cellrobotics.com, or by telephone at 505/343-1131. Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the company's ability to execute its service and product sales plans; and the risks described from time to time in the company's Securities and Exchange Commission filings. -------------------------------------------------------------------------------- Contact: Cell Robotics Inc. Craig Rogers, 719/590-1793 or RCG Capital Markets Group Inc., 480/675-0400 Retail: Jim Estrada, Brett Maas Analysts/Institutional: Joe Dorame Media: Jeff Stanlis rcgonline.com -------------------------------------------------------------------------------- More Quotes and News: Cell Robotics International Inc (OTC BB:CRII.OB - news) Related News Categories: computers, medical/pharmaceutical -------------------------------------------------------------------------------- Help -------------------------------------------------------------------------------- Copyright 1994-1999 Yahoo! All Rights Reserved. Copyright ¸ 1999 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving ina public database, redistributing via a computer network or in a printed form. See our Important Disclaimers and Legal Information. Questions or Comments?